Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

This study has been completed.
Information provided by:
Boston Scientific Corporation Identifier:
First received: March 3, 2006
Last updated: August 28, 2008
Last verified: August 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: May 2003 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):